A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
DuPont de Nemours, Inc.
DD
$57.7B
Mkt Cap
$137.70
+0.22%
DuPont de Nemours, Inc. (DD) has a 5-year average return on invested capital (ROIC) of 0.6%. This is below average and may indicate limited pricing power.
DuPont de Nemours, Inc. (DD) has a market capitalization of $56.4B. It is classified as a large-cap stock.
Yes, DuPont de Nemours, Inc. (DD) pays a dividend with a trailing twelve-month yield of 0.90%.
DuPont de Nemours, Inc. (DD) operates in the Plastic Materials, Synth Resins & Nonvulcan Elastomers industry, within the Materials sector.
DuPont de Nemours, Inc. (DD) reported annual revenue of $6.8 billion in its most recent fiscal year, based on SEC EDGAR filings.
DuPont de Nemours, Inc. (DD) has a net profit margin of -11.4%. The company is currently unprofitable.
DuPont de Nemours, Inc. (DD) generated $227 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
DuPont is a leading provider of advanced solutions across healthcare, water, construction, and industrial markets, operating through two reportable segments: Healthcare & Water Technologies and Diversified Industrials. Healthcare & Water Technologies delivers high-performance medical packaging, components, and devices for biopharma and medical device markets, along with advanced water filtration and purification solutions including ion exchange resins, reverse osmosis elements, and ultrafiltration modules serving industrial wastewater, municipal, and life sciences applications. Diversified Industrials comprises Building Technologies, which provides integrated systems for construction markets including insulation, house wrap, and solid surface products, and Industrial Technologies, which specializes in engineered components and systems for aerospace, automotive, and industrial applications including specialty lubricants, structural adhesives, and printing plates. The company operates through a global footprint with subsidiaries in approximately 50 countries and manufacturing operations in approximately 20 countries, leveraging differentiated technology, application expertise, and established brands to serve regulated and mission-critical customer applications. DuPont's business model emphasizes innovation-driven product development, specialized manufacturing capabilities, and customer partnerships across diverse end markets, with a focus on addressing secular trends including aging populations, water scarcity, and advanced mobility requirements.
【Strong organic growth acceleration】 Management expects organic sales growth to accelerate from 2% in 2025 to approximately 3-4% in 2026, driven by broad-based strength in Healthcare & Water Technologies with mid-single-digit growth in medical packaging, medical devices, and water filtration markets, alongside low single-digit growth in Diversified Industrials supported by aerospace strength and industrial technology demand recovery. Operating margin expansion of 60-80 basis points is anticipated for 2026, with management targeting 150-200 basis points of cumulative margin expansion over the 2026-2028 period through productivity initiatives, business mix improvement, and operational leverage. The company is executing targeted sales plays that combine technologies and application expertise to address specific end markets, with innovation continuing to drive growth through new product launches and market penetration in secular growth areas such as medical device procedures and water treatment. Capital allocation priorities include disciplined share repurchases, a quarterly dividend aligned with a 35-45% payout ratio, and potential strategic acquisitions, while maintaining leverage below 2x net debt to EBITDA.
| Metric | Target | Period |
|---|---|---|
| Net sales | about $7.185 billion | FY2026 |
| Organic sales growth | about 4% | FY2026 |
| Operating EBITDA | about $1.745 billion | FY2026 |
| Adjusted EPS | $2.35-$2.40 per share | FY2026 |
| Operating margin expansion | 60-80 basis points | FY2026 |
| Free cash flow conversion | greater than 90% | FY2026 |
Net sales (FY2026): “For the full year 2026, at the midpoint, we now expect net sales of about $7.185 billion, a net increase of $80 million versus our prior guide.”
Organic sales growth (FY2026): “Our full year net sales guidance now assumes about 4% organic growth, including about 1% from pricing actions taken to fully offset higher input costs due to the Middle East conflict.”
Operating EBITDA (FY2026): “Operating EBITDA at the midpoint is now expected to be about $1.745 billion, primarily reflecting our stronger first quarter results, partially offset by currency headwinds.”
Adjusted EPS (FY2026): “Our adjusted EPS range is now expected to be $2.35-$2.40 per share, a $0.10 increase versus our prior guidance.”
Operating margin expansion (FY2026): “Our full year net sales guidance now assumes about 4% organic growth, including about 1% from pricing actions taken to fully offset higher input costs due to the Middle East conflict.”
Generated solely from the company's own reports listed below — not from third-party data. Hallucination risk is low. · Sources: 10-K, Q4 FY2025 Earnings Call, Q3 FY2025 Earnings Call, Q2 FY2025 Earnings Call, Q1 FY2025 Earnings Call
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 5.5B | 6.8B | 6.7B | 6.6B | 13.0B | 12.6B |
| Net Income | -29M | -779M | 703M | 423M | 5.9B | 6.5B |
| EPS | $-0.07 | $-1.86 | $1.68 | $0.94 | $11.75 | $11.89 |
| Free Cash Flow | 224M | 227M | 480M | 543M | -74M | 1.5B |
| ROIC | 0.2% | -3.8% | 3.0% | 2.4% | - | - |
| Gross Margin | - | 34.5% | 33.0% | 32.8% | 35.5% | 36.6% |
| Debt/Equity | 0.14 | 0.17 | 0.18 | 0.14 | 0.13 | 0.43 |
| Dividends/Share | $1.24 | $1.43 | $1.52 | $1.44 | $1.32 | $1.20 |
| Operating Income | 33M | -364M | 1.3B | 602M | - | - |
| Operating Margin | 0.6% | -5.3% | 19.1% | 9.1% | - | - |
| ROE | -0.2% | -4.2% | 3.0% | 1.7% | 22.1% | 19.9% |
| Shares Outstanding | 410M | 419M | 418M | 450M | 499M | 544M |
| Metric | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||
| Revenue | 48.8B | 48.2B | 62.5B | 22.6B | 21.5B | 20.4B | 12.6B | 13.0B | 6.6B | 6.7B | 6.8B | 5.5B |
| Gross Margin | 22.6% | 21.8% | 20.3% | 30.6% | 53.4% | 65.4% | 36.6% | 35.5% | 32.8% | 33.0% | 34.5% | N/A |
| R&D | 1.6B | 1.6B | 657M | 1.1B | 689M | 565M | 557M | 536M | 192M | 203M | 193M | 103M |
| SG&A | 2.9B | 3.0B | 1.6B | 3.0B | 2.1B | 1.5B | 1.6B | 1.5B | 891M | 976M | 1.0B | 905M |
| EBIT | 10.4B | 4.8B | -611M | 4.1B | 1.2B | -2.2B | N/A | N/A | 602M | 1.3B | -364M | 33M |
| Op. Margin | 21.3% | 10.0% | -1.0% | 18.0% | 5.4% | -10.7% | N/A | N/A | 9.1% | 19.1% | -5.3% | 0.6% |
| Net Income | 7.3B | 4.0B | 1.1B | 3.8B | 497M | -3.0B | 6.5B | 5.9B | 423M | 703M | -779M | -29M |
| Net Margin | 15.0% | 8.2% | 1.8% | 16.9% | 2.3% | -14.5% | 51.5% | 45.1% | 6.4% | 10.5% | -11.4% | -0.5% |
| Non-Recurring | 5.2B | 809M | 1.5B | 240M | 547M | 2.7B | 221M | 139M | 778M | 61M | 154M | 150M |
| Returns on Capital | ||||||||||||
| ROIC | 46.0% | 16.8% | 1.3% | 2.5% | 1.6% | -5.8% | N/A | N/A | 2.4% | 3.0% | -3.8% | 0.2% |
| ROE | 29.4% | 15.2% | 1.8% | 3.9% | 0.7% | -7.4% | 19.9% | 22.1% | 1.7% | 3.0% | -4.2% | -0.2% |
| ROA | 10.7% | 5.4% | 0.8% | 2.0% | 0.4% | -4.2% | 11.1% | 13.5% | 1.1% | 1.9% | -2.7% | -0.1% |
| Cash Flow | ||||||||||||
| Op. Cash Flow | 7.6B | -3.0B | -765M | 4.7B | 1.4B | 4.1B | 2.3B | 588M | 845M | 765M | 560M | 410M |
| Free Cash Flow | 3.9B | -6.8B | -1.5B | 3.5B | -1.1B | 2.9B | 1.5B | -74M | 543M | 480M | 227M | 224M |
| Owner Earnings | 4.7B | -6.1B | -1.9B | 2.4B | -1.9B | 908M | 1.1B | -622M | 208M | 74M | -125M | -138M |
| CapEx | 3.7B | 3.8B | 738M | 1.3B | 2.5B | 1.2B | 788M | 662M | 302M | 285M | 333M | 186M |
| Maint. CapEx | 2.5B | 2.9B | 1.1B | 2.2B | 3.2B | 3.1B | 1.1B | 1.1B | 580M | 635M | 647M | 509M |
| Growth CapEx | 1.2B | 942M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| D&A | 2.5B | 2.9B | 1.1B | 2.2B | 3.2B | 3.1B | 1.1B | 1.1B | 580M | 635M | 647M | 509M |
| CapEx/OCF | N/A | 67.9% | 43.2% | 81.1% | N/A | 29.2% | 39.1% | 53.0% | 28.3% | 12.3% | 59.5% | 45.4% |
| Capital Allocation | ||||||||||||
| Dividends Paid | 2.3B | 2.5B | 3.4B | 3.5B | 1.6B | 882M | 630M | 652M | 651M | 635M | 597M | 507M |
| Dividend Yield | N/A | 26.4% | 58.8% | 40.6% | 8.2% | 6.0% | 4.0% | 5.1% | 5.1% | 4.8% | 4.5% | 0.9% |
| Share Buybacks | 1.2B | 916M | 8.1B | 4.4B | 2.3B | 232M | 2.1B | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | 1.6% | 1.0% | 9.1% | 1.8% | 2.1% | 5.3% | N/A | N/A | N/A | N/A | 0.0% |
| Stock-Based Comp | 352M | 261M | 99M | 128M | 84M | 93M | 26M | 75M | 57M | 56M | 38M | 39M |
| Debt Repayment | 1.1B | 588M | 663M | 9.0B | 6.9B | 2.0B | 5.0B | 600M | 300M | 687M | 4.1B | 4.1B |
| Balance Sheet | ||||||||||||
| Net Debt | -8.5B | 13.5B | 23.7B | -1.9B | 12.5B | 7.3B | 9.4B | -1.4B | 1.0B | 2.3B | 1.6B | 1.3B |
| Cash & Equiv. | 8.6B | 6.6B | 13.4B | 8.5B | 1.5B | 2.5B | 2.0B | 3.7B | 2.4B | 1.8B | 715M | 710M |
| Long-Term Debt | 1.4B | 19.2B | 34.1B | 6.0B | 5.8B | 15.6B | 10.6B | 2.8B | 2.9B | 2.0B | 2.0B | 2.0B |
| Debt/Equity | 0.05 | 0.77 | 0.38 | 0.07 | 0.34 | 0.42 | 0.43 | 0.13 | 0.14 | 0.18 | 0.17 | 0.14 |
| Interest Coverage | 11.0 | 5.6 | -611.0 | 74.1 | 1.7 | -3.3 | N/A | N/A | 1.5 | 3.5 | -1.2 | -1.2 |
| Equity | 26.2B | 26.0B | 100.3B | 94.3B | 41.0B | 38.5B | 26.4B | 26.6B | 24.3B | 23.4B | 13.9B | 14.0B |
| Total Assets | 67.9B | 79.5B | 191.9B | 187.9B | 69.3B | 70.9B | 45.7B | 41.4B | 38.6B | 36.6B | 21.6B | 21.4B |
| Total Liabilities | 40.9B | 52.3B | 90.0B | 92.0B | 27.8B | 31.8B | 18.7B | 14.3B | 13.8B | 12.8B | 7.5B | 7.2B |
| Intangibles | N/A | 6.0B | 33.3B | 14.7B | 13.6B | 8.1B | 6.2B | 5.5B | 5.8B | 3.2B | 2.9B | 2.9B |
| Retained Earnings | N/A | 30.3B | 29.2B | 30.3B | -8.4B | -11.6B | -23.2B | -21.1B | -22.9B | -23.1B | -24.3B | -24.2B |
| Working Capital | N/A | 11.1B | 23.8B | 53.3B | 1.7B | 16.8B | 9.4B | 7.5B | 4.4B | 15.3B | 3.3B | 3.5B |
| Current Assets | 17.9B | 23.7B | 49.9B | 126.7B | 10.0B | 29.0B | 14.3B | 11.3B | 7.5B | 20.8B | 5.6B | 5.6B |
| Current Liabilities | N/A | 12.6B | 26.1B | 73.3B | 8.3B | 12.2B | 4.9B | 3.7B | 3.1B | 5.5B | 2.3B | 2.1B |
| Per Share Data | ||||||||||||
| EPS | 18.45 | 10.56 | 6.45 | 14.88 | 0.67 | -4.01 | 11.89 | 11.75 | 0.94 | 1.68 | -1.86 | -0.07 |
| Owner EPS | 11.97 | -16.23 | -10.83 | 9.46 | -2.52 | 1.23 | 2.10 | -1.25 | 0.46 | 0.18 | -0.30 | -0.34 |
| Book Value | 66.23 | 69.37 | 564.68 | 366.53 | 55.25 | 52.32 | 48.60 | 53.20 | 53.95 | 55.80 | 33.23 | 34.25 |
| Cash Flow/Share | 19.24 | -7.89 | -4.31 | 18.39 | 1.90 | 5.56 | 4.19 | 1.18 | 1.88 | 1.83 | 1.34 | 1.17 |
| Dividends/Share | 5.16 | 5.52 | 15.84 | 13.68 | 2.16 | 1.20 | 1.20 | 1.32 | 1.44 | 1.52 | 1.43 | 1.24 |
| Shares Out. | 395.3M | 374.6M | 177.7M | 257.3M | 741.8M | 735.9M | 543.9M | 499.4M | 450.0M | 418.5M | 418.8M | 409.9M |
| Valuation | ||||||||||||
| P/E Ratio | N/A | 13.6 | 66.6 | 39.7 | 84.1 | N/A | 6.2 | 5.4 | 78.4 | 18.6 | N/A | N/A |
| P/FCF | N/A | N/A | N/A | 2.0 | N/A | 6.6 | 11.3 | N/A | 25.5 | 27.3 | 75.8 | 252.0 |
| EV/EBIT | N/A | 13.9 | 58.5 | 11.8 | 40.1 | N/A | N/A | N/A | 39.6 | 11.9 | N/A | N/A |
| Price/Book | N/A | 2.3 | 1.0 | 0.5 | 1.0 | 1.2 | 1.5 | 1.2 | 1.4 | 0.6 | 1.2 | 4.0 |
| Price/Sales | N/A | 1.1 | 1.4 | 0.7 | 2.2 | 2.5 | 3.0 | 2.3 | 2.5 | 2.0 | 1.9 | 10.3 |
| FCF Yield | N/A | -11.5% | -1.5% | 7.1% | -2.5% | 6.3% | 3.7% | -0.2% | 1.6% | 3.7% | 1.3% | 0.4% |
| Market Cap | 0 | 58.6B | 97.3B | 48.4B | 41.9B | 45.7B | 40.2B | 31.7B | 33.2B | 13.1B | 17.2B | 56.4B |
| Avg. Price | 0.00 | 24.91 | 32.46 | 33.44 | 26.44 | 19.99 | 29.12 | 25.60 | 28.54 | 31.64 | 31.74 | 137.70 |
| Year-End Price | 0.00 | 28.46 | 36.11 | 27.40 | 23.59 | 25.99 | 30.94 | 26.59 | 30.83 | 31.26 | 41.10 | 137.70 |
DuPont de Nemours, Inc. passes 1 of 9 quality checks, indicating weak fundamentals.
On a free-cash-flow basis, the stock trades at 248.1x vs a median of 18.4x. The company's 5-year average ROIC is 0.6% with a gross margin of 34.5%. Total shareholder yield (dividends) is 0.9%. At current prices, the estimated annualized return to fair value is +2.2%.
DuPont de Nemours, Inc. (DD) has a debt-to-equity ratio of 0.17. This indicates a conservatively financed balance sheet.
DuPont de Nemours, Inc. (DD) reported earnings per share (EPS) of $-1.86 in its most recent fiscal year.
DuPont de Nemours, Inc. (DD) has a return on equity (ROE) of -4.2%. A negative ROE may indicate losses or negative equity.
DuPont de Nemours, Inc. (DD) has a 5-year average gross margin of 34.5%. This indicates decent pricing power.
The Ledger Terminal provides 11 years of financial data for DuPont de Nemours, Inc. (DD), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
DuPont de Nemours, Inc. (DD) has a book value per share of $33.23, based on its most recent annual SEC filing.
Based on recent SEC filings and earnings disclosures, Management expects organic sales growth to accelerate from 2% in 2025 to approximately 3-4% in 2026, driven by broad-based strength in Healthcare & Water Technologies with mid-single-digit growth in medical packaging, medical devices, and water filtration markets, alongside low single-digit growth in Diversified Industrials supported by aerospace strength and industrial technology demand recovery. Operating margin expansion of 60-80 basis points is anticipated for 2026, with management targeting 150-200 basis points of cumulative margin expansion over the 2026-2028 period through productivity initiatives, business mix improvement, and operational leverage. The company is executing targeted sales plays that combine technologies and application expertise to address specific end markets, with innovation continuing to drive growth through new product launches and market penetration in secular growth areas such as medical device procedures and water treatment. Capital allocation priorities include disciplined share repurchases, a quarterly dividend aligned with a 35-45% payout ratio, and potential strategic acquisitions, while maintaining leverage below 2x net debt to EBITDA.
Based on recent SEC filings and earnings calls, DuPont de Nemours, Inc. (DD) has provided the following forward guidance: Net sales: about $7.185 billion (FY2026); Organic sales growth: about 4% (FY2026); Operating EBITDA: about $1.745 billion (FY2026); Adjusted EPS: $2.35-$2.40 per share (FY2026); Operating margin expansion: 60-80 basis points (FY2026), plus 1 additional metric.
Free cash flow conversion (FY2026): “Free cash flow generation will be solid with an expected conversion of greater than 90%.”